Back to search
FDAFDA · Food and drugs·Recall number D-0007-2026

Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28

Published October 15, 2025 · Recall initiated: September 2, 2025

Summary

FDA records drug Class II recall D-0007-2026, published October 15, 2025 and initiated September 2, 2025. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 2192 cartons; Lot: Lot # LF41138A; Exp 06/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Content Uniformity Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if NORGESTIMATE AND ETHINYL ESTRADIOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NORGESTIMATE AND ETHINYL ESTRADIOL
Manufacturer
AvKARE
Distributor
U.S. Nationwide
Lot
Lot # LF41138A; Exp 06/30/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28 recalled?

Yes. FDA published recall D-0007-2026 on October 15, 2025. Reported hazard: Failed Content Uniformity Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NORGESTIMATE AND ETHINYL ESTRADIOL.